Suppr超能文献

CD4、CD8与TCR - CD3复合物:一类新型蛋白酪氨酸激酶受体。

CD4, CD8 and the TCR-CD3 complex: a novel class of protein-tyrosine kinase receptor.

作者信息

Rudd C E

机构信息

Division of Tumor Immunology, Dana-Farber Cancer Institute, Boston, MA.

出版信息

Immunol Today. 1990 Nov;11(11):400-6. doi: 10.1016/0167-5699(90)90159-7.

Abstract

A novel form of receptor-kinase interaction was first described in the interaction between the CD4 and CD8 antigens and the protein-tyrosine kinase p56lck. This linkage, between a regulatory antigen on T cells and a member of a family of intracellular molecules with an established ability to activate and transform cells, is likely to be of great importance in the regulation of T-cell growth. Recently, data have been obtained on the molecular basis of regulation of the CD4/CD8-p56lck interaction and an interaction between the T-cell receptor complex (TCR-CD3) and another src-kinase p59fyn has been described. Here, Christopher Rudd examines these interactions and outlines their potential roles in normal and malignant T-cell growth.

摘要

一种新型的受体 - 激酶相互作用首次在CD4和CD8抗原与蛋白酪氨酸激酶p56lck的相互作用中被描述。这种T细胞上的调节性抗原与一族具有激活和转化细胞既定能力的细胞内分子成员之间的联系,在T细胞生长调节中可能具有重要意义。最近,已获得关于CD4/CD8 - p56lck相互作用调节的分子基础的数据,并且还描述了T细胞受体复合物(TCR - CD3)与另一种src激酶p59fyn之间的相互作用。在此,克里斯托弗·拉德研究了这些相互作用,并概述了它们在正常和恶性T细胞生长中的潜在作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验